Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis - 27/12/12
, Boris Perelman, PhD a, Gary Liss, MD, MS b
Corresponding author: Peter Vadas, MD, PhD, Division of Allergy and Clinical Immunology, Department of Medicine, St Michael’s Hospital, University of Toronto, Carter Wing 8-161, 30 Bond St, Toronto, ON M5B IW8, Canada.Abstract |
Background |
Platelet-activating factor (PAF) is an important mediator and correlates with anaphylaxis severity. How well PAF correlates with severity relative to histamine or tryptase is not known.
Objective |
To analyze the levels of PAF, histamine, and tryptase as a function of severity in patients with acute allergic reactions.
Methods |
PAF, histamine, and tryptase levels were measured in blood samples collected from 23 healthy volunteers and from 41 patients during acute allergic reactions. Reactions were stratified by severity from grade 1 (least severe) to grade 3 (most severe).
Results |
Among the 3 reaction grades, there were significant differences by ANOVA for PAF (P < .0001). The proportion of elevated PAF values increased across severity groups (P = .0009). Increased PAF levels were observed in 20%, 66.7%, and 100% of the patients with grades 1, 2, and 3 allergic reactions, respectively. While the proportion of elevated histamine values increased from 40% to 57% to 70% across grades 1, 2, and 3, respectively, these were not significantly different (P = .40). For tryptase, the proportion of elevated values increased monotonically from 0 in grade 1 to 4.8% in grade 2 to 60% in grade 3 (P = .0002).
Conclusions |
The PAF level was significantly elevated in proportion to the severity of acute allergic reactions. Whereas the PAF level was elevated in all patients with severe anaphylaxis, this was not true for either histamine or tryptase. Neither histamine nor tryptase showed as good correlations with severity scores as did PAF. These data are consistent with a pivotal role for PAF as a mediator of anaphylaxis.
Le texte complet de cet article est disponible en PDF.Key words : Platelet-activating factor, histamine, tryptase, anaphylaxis, emergency department
Abbreviations used : PAF, PAF-AH
Plan
| This study was supported by grants-in-aid from the National Peanut Board and the Ganz Family Foundation. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 131 - N° 1
P. 144-149 - janvier 2013 Retour au numéro
Article précédent
- Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening study
- George Du Toit, Graham Roberts, Peter H. Sayre, Marshall Plaut, Henry T. Bahnson, Herman Mitchell, Suzana Radulovic, Susan Chan, Adam Fox, Victor Turcanu, Gideon Lack, Learning Early About Peanut Allergy (LEAP) Study Team
- Parent report of physician diagnosis in pediatric food allergy
- Ruchi S. Gupta, Elizabeth E. Springston, Bridget Smith, Jacqueline Pongracic, Jane L. Holl, Manoj R. Warrier
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?